PortfoliosLab logo

VanEck Vectors Biotech ETF

BBH
ETF · Currency in USD
ISIN
US92189F7261
CUSIP
92189F726
Issuer
VanEck
Inception Date
Dec 20, 2011
Region
North America (U.S.)
Category
Health & Biotech Equities
Expense Ratio
0.35%
Index Tracked
MVIS US Listed Biotech 25 Index
ETF Home Page
www.vaneck.com
Asset Class
Equity

Asset Class Size

Multi-Cap

Asset Class Style

Growth

BBHPrice Chart


Click Calculate to get results
S&P 500

BBHPerformance

The chart shows the growth of $10,000 invested in VanEck Vectors Biotech ETF on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $71,769 for a total return of roughly 617.69%. All prices are adjusted for splits and dividends.


BBH (VanEck Vectors Biotech ETF)
Benchmark (S&P 500)

BBHReturns in periods

Returns over 1 year are annualized

PeriodReturn
1M2.55%
6M13.13%
YTD21.98%
1Y23.83%
5Y12.87%
10Y20.13%

BBHMonthly Returns Heatmap


Click Calculate to get results

BBHSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current VanEck Vectors Biotech ETF Sharpe ratio is 1.01. A Sharpe ratio greater than 1.0 is considered acceptable.

The chart below displays rolling 12-month Sharpe Ratio.


BBH (VanEck Vectors Biotech ETF)
Benchmark (S&P 500)

BBHDividends

VanEck Vectors Biotech ETF granted a 0.29% dividend yield in the last twelve months, as of Jul 31, 2021. The annual payout for that period amounted to $0.61 per share.


PeriodTTM20202019201820172016201520142013201220112010
Dividend$0.61$0.61$0.47$0.55$0.68$0.33$0.34$0.00$0.00$0.18$3.69$0.00

Dividend yield

0.29%0.36%0.34%0.50%0.55%0.30%0.27%0.00%0.00%0.34%10.13%0.00%

BBHDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


BBH (VanEck Vectors Biotech ETF)
Benchmark (S&P 500)

BBHWorst Drawdowns

The table below shows the maximum drawdowns of the VanEck Vectors Biotech ETF. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the VanEck Vectors Biotech ETF is 33.76%, recorded on Feb 8, 2016. It took 975 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-33.76%Jul 21, 2015140Feb 8, 2016975Dec 20, 20191115
-22%Feb 25, 201434Apr 11, 201494Aug 26, 2014128
-20.88%Feb 24, 202016Mar 16, 202023Apr 17, 202039
-19.68%Mar 23, 201046May 26, 2010221Apr 11, 2011267
-18.37%Jul 5, 201127Aug 10, 201155Oct 27, 201182
-14.79%Jul 21, 202037Sep 10, 202069Dec 17, 2020106
-14.49%Feb 16, 202113Mar 4, 202167Jun 9, 202180
-11.98%May 15, 201328Jun 24, 201312Jul 11, 201340
-10.72%Oct 8, 201222Nov 8, 201240Jan 8, 201362
-10.21%Sep 25, 201414Oct 14, 20147Oct 23, 201421

BBHVolatility Chart

Current VanEck Vectors Biotech ETF volatility is 23.42%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


BBH (VanEck Vectors Biotech ETF)
Benchmark (S&P 500)

Portfolios with VanEck Vectors Biotech ETF


Loading data...

More Tools for VanEck Vectors Biotech ETF